tiprankstipranks
Trending News
More News >
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV
US Market
Advertisement

Plus Therapeutics (PSTV) Income Statement

Compare
918 Followers

Plus Therapeutics Income Statement

Last quarter (Q1 2025), Plus Therapeutics's total revenue was $1.06M, a decrease of -36.85% from the same quarter last year. In Q1, Plus Therapeutics's net income was $-17.40M. See Plus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.82M$ 4.91M$ 224.00K$ 0.00$ 303.00K
Gross Profit
$ 4.97M$ -4.78M$ -488.00K$ -66.00K$ -2.40M
Operating Expenses
$ 19.67M$ 8.54M$ 19.71M$ 12.43M$ 9.89M
Depreciation and Amortization
$ 852.00K$ 628.00K$ 619.00K$ 419.00K$ 369.00K
EBITDA
$ -8.40M$ -12.69M$ -18.85M$ -12.05M$ -6.76M
Operating Income
$ -14.70M$ -13.32M$ -19.71M$ -12.49M$ -9.58M
Other Income/Expenses
$ 1.72M$ 5.00K$ -563.00K$ -907.00K$ 1.34M
Pretax Income
$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Net Income
$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Per Share Metrics
Basic EPS
$ -1.95$ -4.24$ -11.55$ -17.78$ -27.90
Diluted EPS
$ -2.34$ -4.24$ -11.55$ -17.78$ -27.90
Weighted Average Shares Outstanding
6.64M 3.14M 1.75M 804.74K 295.19K
Weighted Average Shares Outstanding (Diluted)
7.70M 3.14M 1.75M 805.95K 295.19K
Currency in USD

Plus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis